(Q46832775)

25 December 2017

title

Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast (English)

1 reference

25 December 2017

invasive ductal carcinoma

main subject

1 reference

Park SS

1

1 reference

25 December 2017

Kim JE

2

1 reference

25 December 2017

Kim YA

3

1 reference

25 December 2017

Kim YC

4

1 reference

25 December 2017

Kim SW

5

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

published in

Histopathology

1 reference

25 December 2017

volume

47

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

625-630

1 reference

25 December 2017

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

The caveolae membrane system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Emerging themes in lipid rafts and caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Reduction of caveolin 1 gene expression in lung carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Caveolin-1, a putative tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02303.X

10.1111/J.1365-2559.2005.02303.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16324201

1 reference

25 December 2017